GlassScriptPhysician profile
David Kalambet
NPI 1164115556
$4,831.76
in general payments reported to CMS, 2019-2025
24 companies · $2,877 in 2025
The $2,877 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $219 · 2024: $1,736 · 2025: $2,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,179 · Travel and Lodging: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,178.63 |
| Travel and Lodging | $653.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,267.10 | 2025 | Ortholoc 2 Lapifuse, Augment Injectable, Ortholoc 3di Crosscheck |
| Acumed LLC | $564.30 | 2023-2025 | Acumed, Acumed, Osteomed |
| Bone Support INC. | $505.61 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Paragon 28, INC. | $319.14 | 2023-2025 | Bun-Yo-Matic, Monkey Bars |
| Depuy Synthes Sales INC. | $304.76 | 2024-2025 | Motoband, Motoband Cp, Crosstie |
| Kerecis Limited | $295.32 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $231.06 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kuros Biosciences USA, INC | $223.73 | 2024-2025 | Magnetos |
| Pinnacle, INC | $217.53 | 2024-2025 | |
| Solventum Corporation | $213.68 | 2024-2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Davol INC. | $124.71 | 2025 | Surgiphor, Arista |
| Orthofix Medical, INC. | $111.50 | 2024-2025 | Physio-Stim, Truelok, Ankle Hindfoot Nailing System |
| Medtronic, INC. | $110.60 | 2024 | Venaseal |
| Averitas Pharma INC. | $85.10 | 2024-2025 | Qutenza |
| Surgenex LLC | $36.26 | 2025 | Surgraft, Renograft, Surmatrix |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $32.11 | 2024 | |
| Bioventus LLC | $29.97 | 2024 | Exogen Ultrasound Bone Healing System |
| Lifenet Health | $24.38 | 2024 | Theragenesis Wound Matrix |
| Aroa Biosurgery Incorporated | $24.25 | 2024 | |
| Organogenesis INC. | $23.96 | 2025 | Puraply Wound Matrix |
| Heron Therapeutics, INC. | $23.55 | 2025 | Zynrelef |
| Mimedx Group, INC. | $23.43 | 2025 | |
| Paratek Pharmaceuticals, INC. | $21.92 | 2024 | Nuzyra |
| Amgen INC. | $17.79 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kalambet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.